CD45 and multiple sclerosis: The exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers

Macarena Gomez-Lira, Maria Liguori, Corrado Magnani, Deborah Bonamini, Alessandro Salviati, Maurizio Leone, Virginia Andreoli, Maria Trojano, Paola Valentino, Giovanni Savettieri, Aldo Quattrone, Pier Franco Pignatti, Patricia Momigliano-Richiardi, Mara Giordano

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We re-evaluated the association with multiple sclerosis (MS) of the C77G splicing regulatory variation in the CD45 gene and screened for new mutations the three alternatively spliced exons (#4, 5 and 6). No association with C77G was detected in two groups of patients (total=448) and controls (total=559) from Northern and Southern Italy. When excluding the first published study indicating a positive association, a meta-analysis of the five further studies conducted to date (including the present one) led to a non-significant combined odds ratio (OR) of 1.11. None of the four newly identified nucleotide substitutions, namely C77T (Pro59Pro) in exon 4, G69C (Asp121His) in exon 5, T127A (Ile187Asn) and A138G (Thr191Ala) in exon 6, was significantly associated to MS.

Original languageEnglish
Pages (from-to)216-221
Number of pages6
JournalJournal of Neuroimmunology
Volume140
Issue number1-2
DOIs
Publication statusPublished - Jul 2003

Fingerprint

Multiple Sclerosis
Meta-Analysis
Exons
Italy
Nucleotides
Odds Ratio
Mutation
Genes

Keywords

  • Association study
  • CD45
  • Meta-analysis
  • Multiple sclerosis

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

CD45 and multiple sclerosis : The exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers. / Gomez-Lira, Macarena; Liguori, Maria; Magnani, Corrado; Bonamini, Deborah; Salviati, Alessandro; Leone, Maurizio; Andreoli, Virginia; Trojano, Maria; Valentino, Paola; Savettieri, Giovanni; Quattrone, Aldo; Pignatti, Pier Franco; Momigliano-Richiardi, Patricia; Giordano, Mara.

In: Journal of Neuroimmunology, Vol. 140, No. 1-2, 07.2003, p. 216-221.

Research output: Contribution to journalArticle

Gomez-Lira, M, Liguori, M, Magnani, C, Bonamini, D, Salviati, A, Leone, M, Andreoli, V, Trojano, M, Valentino, P, Savettieri, G, Quattrone, A, Pignatti, PF, Momigliano-Richiardi, P & Giordano, M 2003, 'CD45 and multiple sclerosis: The exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers', Journal of Neuroimmunology, vol. 140, no. 1-2, pp. 216-221. https://doi.org/10.1016/S0165-5728(03)00208-X
Gomez-Lira, Macarena ; Liguori, Maria ; Magnani, Corrado ; Bonamini, Deborah ; Salviati, Alessandro ; Leone, Maurizio ; Andreoli, Virginia ; Trojano, Maria ; Valentino, Paola ; Savettieri, Giovanni ; Quattrone, Aldo ; Pignatti, Pier Franco ; Momigliano-Richiardi, Patricia ; Giordano, Mara. / CD45 and multiple sclerosis : The exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers. In: Journal of Neuroimmunology. 2003 ; Vol. 140, No. 1-2. pp. 216-221.
@article{37443dddf03340319a0f94aeb6928d87,
title = "CD45 and multiple sclerosis: The exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers",
abstract = "We re-evaluated the association with multiple sclerosis (MS) of the C77G splicing regulatory variation in the CD45 gene and screened for new mutations the three alternatively spliced exons (#4, 5 and 6). No association with C77G was detected in two groups of patients (total=448) and controls (total=559) from Northern and Southern Italy. When excluding the first published study indicating a positive association, a meta-analysis of the five further studies conducted to date (including the present one) led to a non-significant combined odds ratio (OR) of 1.11. None of the four newly identified nucleotide substitutions, namely C77T (Pro59Pro) in exon 4, G69C (Asp121His) in exon 5, T127A (Ile187Asn) and A138G (Thr191Ala) in exon 6, was significantly associated to MS.",
keywords = "Association study, CD45, Meta-analysis, Multiple sclerosis",
author = "Macarena Gomez-Lira and Maria Liguori and Corrado Magnani and Deborah Bonamini and Alessandro Salviati and Maurizio Leone and Virginia Andreoli and Maria Trojano and Paola Valentino and Giovanni Savettieri and Aldo Quattrone and Pignatti, {Pier Franco} and Patricia Momigliano-Richiardi and Mara Giordano",
year = "2003",
month = "7",
doi = "10.1016/S0165-5728(03)00208-X",
language = "English",
volume = "140",
pages = "216--221",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier Science B.V.",
number = "1-2",

}

TY - JOUR

T1 - CD45 and multiple sclerosis

T2 - The exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers

AU - Gomez-Lira, Macarena

AU - Liguori, Maria

AU - Magnani, Corrado

AU - Bonamini, Deborah

AU - Salviati, Alessandro

AU - Leone, Maurizio

AU - Andreoli, Virginia

AU - Trojano, Maria

AU - Valentino, Paola

AU - Savettieri, Giovanni

AU - Quattrone, Aldo

AU - Pignatti, Pier Franco

AU - Momigliano-Richiardi, Patricia

AU - Giordano, Mara

PY - 2003/7

Y1 - 2003/7

N2 - We re-evaluated the association with multiple sclerosis (MS) of the C77G splicing regulatory variation in the CD45 gene and screened for new mutations the three alternatively spliced exons (#4, 5 and 6). No association with C77G was detected in two groups of patients (total=448) and controls (total=559) from Northern and Southern Italy. When excluding the first published study indicating a positive association, a meta-analysis of the five further studies conducted to date (including the present one) led to a non-significant combined odds ratio (OR) of 1.11. None of the four newly identified nucleotide substitutions, namely C77T (Pro59Pro) in exon 4, G69C (Asp121His) in exon 5, T127A (Ile187Asn) and A138G (Thr191Ala) in exon 6, was significantly associated to MS.

AB - We re-evaluated the association with multiple sclerosis (MS) of the C77G splicing regulatory variation in the CD45 gene and screened for new mutations the three alternatively spliced exons (#4, 5 and 6). No association with C77G was detected in two groups of patients (total=448) and controls (total=559) from Northern and Southern Italy. When excluding the first published study indicating a positive association, a meta-analysis of the five further studies conducted to date (including the present one) led to a non-significant combined odds ratio (OR) of 1.11. None of the four newly identified nucleotide substitutions, namely C77T (Pro59Pro) in exon 4, G69C (Asp121His) in exon 5, T127A (Ile187Asn) and A138G (Thr191Ala) in exon 6, was significantly associated to MS.

KW - Association study

KW - CD45

KW - Meta-analysis

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0038642831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038642831&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(03)00208-X

DO - 10.1016/S0165-5728(03)00208-X

M3 - Article

C2 - 12864992

AN - SCOPUS:0038642831

VL - 140

SP - 216

EP - 221

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -